SIMPONI (golimumab) Patient Assistance Program
Don’t let the high cost of brand specialty TNF biologics stand between you and the treatment you need. We help eligible patients access Simponi (golimumab) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Simponi (golimumab) is FDA-approved for moderately to severely active rheumatoid arthritis (in combination with methotrexate), active psoriatic arthritis, active ankylosing spondylitis, and moderately to severely active ulcerative colitis. A separate IV form (Simponi Aria) is also FDA-approved for some indications.
- Without assistance, the average retail price for SC Simponi runs approximately $6,500–$7,800 per monthly dose, with annual costs commonly $80,000+.
- Through AffordMyPrescriptions, qualifying patients can access Simponi for a flat $69.95 per month — our advocacy team manages the entire enrollment, refills, and renewal process.
- There is no biosimilar version of Simponi available in the U.S. as of 2026 — but multiple TNF inhibitor biosimilars (adalimumab and infliximab) are now available as alternatives.
What Is Simponi Prescription Assistance Program?
The Simponi Prescription Assistance Program is a manufacturer-sponsored initiative that provides Simponi at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for patients with RA, PsA, AS, or UC who are uninsured or underinsured, as well as Medicare Part D beneficiaries.
Navigating the program on your own means dealing with eligibility verification, rheumatology/gastroenterology coordination, TB screening, prior-authorization documentation, and renewal deadlines.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing refill coordination and annual re-certification — so you focus on your health, not paperwork.
Pharmacy Price Comparison
- Without assistance, brand Simponi costs roughly $6,500–$7,800 per monthly dose. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$7,500.00 | Save ~$7,430/mo |
| CVS Pharmacy | ~$7,800.00 | Save ~$7,730/mo |
| Walmart | ~$7,000.00 | Save ~$6,930/mo |
| Costco | ~$6,700.00 | Save ~$6,630/mo |
| Specialty Pharmacy | ~$6,800.00 | Save ~$6,730/mo |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Simponi Prescription Program?
The Patient Assistance Program is free to apply for and provides Simponi at no medication cost if approved. But the process involves detailed applications, prescriber coordination, TB screening documentation, specialty pharmacy logistics, and ongoing renewal management. Our $69.95/month service covers full advocacy.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Simponi:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
- Still $6,500–$7,800 per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Simponi assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Simponi Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Simponi:
Simponi (golimumab) is a biologic medicine in the tumor necrosis factor alpha (TNF-alpha) inhibitor class used to treat several immune-mediated inflammatory conditions — moderately to severely active rheumatoid arthritis, active psoriatic arthritis, active ankylosing spondylitis, and moderately to severely active ulcerative colitis. It is given as a once-monthly subcutaneous injection (50 mg). A separate IV form (Simponi Aria) is also available.
How Simponi Works:
Simponi is a fully human monoclonal antibody that targets TNF-alpha, an inflammatory cytokine responsible for joint destruction and intestinal inflammation in conditions like RA and UC. By binding to and neutralizing this protein, Simponi prevents it from interacting with immune cell receptors, thereby dampening the inflammatory cascade. Its primary benefit is providing consistent relief with a convenient once-monthly dosing schedule.
Form and use:
This medication is typically administered as a 50 mg subcutaneous injection once a month using a prefilled syringe or an autoinjector. For patients with ulcerative colitis, a higher induction dose is required at the start of therapy before moving to the monthly maintenance schedule. While an IV version exists with different requirements, the subcutaneous form can be self-administered at home after proper training.
Generic availability:
As of 2026, there is no FDA-approved biosimilar version of Simponi available in the United States. While several other TNF inhibitors, such as Humira and Remicade, have lower-cost biosimilars on the market, Simponi remains available only as a brand-name product. Choosing between Simponi and these alternatives depends on a patient’s specific diagnosis, medical history, and overall tolerability.
Warnings:
Simponi carries serious warnings regarding life-threatening infections, including tuberculosis (TB) reactivation and sepsis, as well as risks for certain malignancies like lymphoma. Patients must undergo TB screening before beginning treatment and should be monitored for heart failure, hepatitis B reactivation, and demyelinating diseases. Any new symptoms, such as persistent cough, fever, or unusual fatigue, should be reported to a doctor immediately.
FAQ (Frequently Asked Questions)
How Much Does Simponi Cost Without Insurance?
The average retail price runs approximately $6,500–$7,800 per monthly dose. Annual costs commonly reach $80,000+. Through AffordMyPrescriptions, qualifying patients receive Simponi at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
Are There Other TNF Biologics Or Biosimilars I Should Know About?
Yes. Other TNF inhibitors include adalimumab/Humira (with multiple biosimilars at lower cost), infliximab/Remicade (with multiple biosimilars), etanercept/Enbrel (no biosimilar yet in the U.S.), and certolizumab pegol/Cimzia. Biosimilars to adalimumab and infliximab are now widely available at significantly lower cost. Whether a different TNF inhibitor or biosimilar would work for you is a decision for your prescriber. We mention this directly because if a biosimilar would work for you, that may be a better path.
How Is Simponi Different From Simponi Aria?
Simponi is the subcutaneous (SC) self-injection form (50 mg once monthly). Simponi Aria is the intravenous (IV) infusion form (2 mg/kg at weeks 0, 4, then every 8 weeks for some indications), given in a clinic or infusion center. Both contain the same active ingredient (golimumab), but the SC and IV forms have different administration logistics and slightly different approved indications.
Do I Need Tests Before Starting Simponi?
Yes. Patients are typically screened for tuberculosis (latent and active) before starting Simponi, and HBV screening is also typically done. Your prescriber will review your medical history, including any history of heart failure, demyelinating disease, recurrent infections, or vaccination needs.Yes. Generic fluticasone propionate (Flovent equivalent) is widely available at $50–$80 per inhaler — much cheaper than brand Arnuity. Other inhaled corticosteroids with generic options include budesonide (Pulmicort, generic). We mention this directly because for many patients, a generic ICS at low cost is the better path. Discuss with your prescriber whether a switch makes sense.
Can I Get Simponi Through The PAP If I Have Medicare?
Yes. Medicare Part D beneficiaries can typically qualify for Simponi Patient Assistance, especially if you face specialty-tier copays you cannot afford. The manufacturer’s commercial copay savings program is reserved for commercially insured patients only — but the underlying PAP supports Medicare patients who meet income criteria.
What If My Application Is Denied?
If your initial application is denied, we explore alternatives — the manufacturer’s copay assistance program if you have commercial insurance, independent foundations such as the Arthritis Foundation, PAN Foundation, HealthWell Foundation, or Crohn’s & Colitis Foundation, or asking your prescriber whether a different TNF biologic (or biosimilar at lower cost) would be appropriate. If we cannot find a path, you will not be charged our service fee.
Take Control of Your Medication Costs
If you are struggling with the high cost of Simponi, our team may be able to help you access assistance programs — or guide you to a cheaper biosimilar TNF biologic if it is the better fit. Check your eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.